Artículos de revistas
Metabolic Profiling Of Human Blood Serum From Treated Patients With Bipolar Disorder Employing 1h Nmr Spectroscopy And Chemometrics
Registro en:
Analytical Chemistry. , v. 81, n. 23, p. 9755 - 9763, 2009.
32700
10.1021/ac901502j
2-s2.0-73249130205
Autor
Sussulini A.
Prando A.
Maretto D.A.
Poppi R.J.
Tasic L.
Banzato C.E.M.
Arruda M.A.Z.
Institución
Resumen
Metabolic profiling employing hydrogen nuclear magnetic resonance ( 1H NMR) spectroscopy and chemometric analysis of human blood serum samples taken from the control group ( n = 25) and patients with bipolar disorder ( n = 25) was performed to identify molecular changes related to the disorder and to different drug treatments: lithium ( n = 15) versus other medications ( n = 10). This strategy showed significant potential for exploring pathophysiological and toxicological features involved in bipolar disorder. The investigated groups (control and patients with bipolar disorder under different treatments) could be distinguished according to their metabolic profiles, and the main differential metabolites found were lipids, lipid-metabolism-related molecules (acetate, choline, and myo-inositol), and some key amino acids (glutamate, glutamine). Our results suggest that some of the 24 identified metabolites may be linked to lithium- and other-medicationprovoked metabolic changes or may even be directly related to the disorder. Thus, these findings may contribute to paving the way for future studies aiming at identifying potential biomarkers for bipolar disorder. © 2009 American Chemical Society. 81 23 9755 9763 Malhi, G.S., Adams, D., Lampe, L., Paton, M., O'Connor, N., Newton, L.A., Walter, G., Berk, M., (2009) Acta Psychiatr. Scand, 119 (SUPPL. 439), pp. 27-46 (2000) Diagnostic and Statistical Manual for Mental Disorders, text revision (DSM-IV-TR), , American Psychiatric Association, 4th ed, American Psychiatric Association: Washington, DC Depression and Bipolar Support Alliance. Perceptions and Impact of Bipolar Disorder: How Far Have We Really Come? Presented at the Fourth International Conference on Bipolar Disorder, Pittsburgh, PA, June 14-16, 2001Phillips, M.L., Vieta, E., (2007) Schizophr. Bull, 33, pp. 893-904 Marmol, F., (2008) Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 32, pp. 1761-1771 Oswald, P., Souery, D., Kasper, S., Lecrubier, Y., Montgomery, S., Wyckaert, S., Zohar, J., Mendlewicz, J., (2007) Eur. Neuropsychopharmacol, 17, pp. 687-695 Gitlin, M., (2006) Mol. Psychiatry, 11, pp. 227-240 Maj, M., (2003) Bipolar Disord, 5, pp. 180-188 Detera-Wadleigh, S.D., MacMahon, F.J., (2006) Biol. Psychiatry, 60, pp. 106-114 Lenz, E.M., Wilson, I.D., (2007) J. Proteome Res, 6, pp. 443-458 Moco, S., Bino, R.J., de Vos, R.C.H., Vervoort, J., (2007) Trends Anal. Chem, 26, pp. 855-866 Wishart, D.S., (2008) Trends Anal. Chem, 27, pp. 228-237 Maher, A.D., Crockford, D., Toft, H., Malmodin, D., Faber, J.H., McCarthy, M.I., Barrett, A., Nicholson, J.K., (2008) Anal. Chem, 80, pp. 7354-7362 Dunn, W.B., Ellis, D.I., (2005) Trends Anal. Chem, 24, pp. 285-294 Kaddurah-Daouk, R., Krishnan, K.R.R., (2009) Neuropsychopharmacology, 34, pp. 173-186 Nicholson, J.K., Lindon, J.C., (2008) Nature, 455, pp. 1054-1056 Nicholson, J.K., Connelly, J., Lindon, J.C., Holmes, E., (2002) Nat. Rev. Drug Discovery, 1, pp. 153-161 Sanacora, G., Rothman, D., Krystal, J.H., (1999) Neuroscientist, 5, pp. 192-196 Öngür, D., Prescot, A.P., Jensen, J.E., Cohen, B.M., Renshaw, P.F., (2009) Psychiatry Res.: Neuroimaging, 172, pp. 44-48 Bertolino, A., Frye, M., Callicott, J.H., Mattay, V.S., Rakow, R., Shelton-Repella, J., Post, R., Weinberger, D.R., (2003) Biol. Psychiatry, 53, pp. 906-913 Lan, M.J., McLoughlin, G.A., Griffin, J.L., Tsang, T.M., Huang, J.T.J., Yuan, P., Manji, H., Bahn, S., (2009) Mol. Psychiatry, 14, pp. 269-279 Teahan, O., Gamble, S., Holmes, E., Waxman, J., Nicholson, J.K., Bevan, C., Keun, H.C., (2006) Anal. Chem, 78, pp. 4307-4318 Diaz, F.J., James, D., Botts, S., Maw, L., Susce, M.T., de Leon, J., (2009) Bipolar Disord, 11, pp. 154-165 Cui, Q., Lewis, I.A., Hegeman, A.D., Anderson, M.E., Li, J., Schulte, C.F., Westler, W.M., Markley, J.L., (2008) Nat. Biotechnol, 26, pp. 162-164 Madison Metabolomics Consortium Database, , http://mmcd.nmrfam.wisc.edu, University of Wisconsin: Madison, WI, Accessed July 20, 2009 Nørgaard, L., The iToolbox for MATLAB KVL: Frederiksberg, , http://www.models.life.ku.dk, Denmark, Accessed July 27, 2009 Sena, M.M., Chaudhry, Z.F., Collins, C.H., Poppi, R.J., (2004) J. Pharm. Biomed. Anal, 36, pp. 743-749 Kato, T., (2001) Neurosci. Res, 40, pp. 105-113 Wold, S., Antii, H., Lindgren, F., Ohman, J., (1998) Chemom. Intell. Lab. Syst, 44, pp. 175-185 Trygg, J., Holmes, E., Lundstedt, T., (2007) J. Proteome Res, 6, pp. 469-479 (2005) PLS Toolbox 3.5 for MATLAB, , Eigenvector Research: Wenatchee, WA de Oliveira, P.R., Tasic, L., Rocco, S.A., Rittner, R., (2006) Magn. Reson. Chem, 44, pp. 790-796 Nicholson, J.K., Foxall, P.J.D., Spraul, M., Farrant, R.D., Lindon, J.C., (1995) Anal. Chem, 67, pp. 793-811 Tang, H., Wang, Y., Nicholson, J.K., Lindon, J.C., (2004) Anal. Biochem, 325, pp. 260-272 Miller, J.C., Miller, J.N., (2005) Statistics and Chemometrics for Analytical Chemistry, , 4th ed, Pearson Prentice Hall: Upper Saddle River, NJ Atmaca, M., Kuloglu, M., Tezcan, E., Ustundag, B., Bayik, Y., (2002) Neuropsychobiology, 46, pp. 176-179 Ozbulut, O., Guler, O., Kurt, E., Alatas, G., Serteser, M., Gecici, O., (2007) Neurol. Psychiatry Brain Res, 14, pp. 127-130 Schwarz, E., Prabakaran, S., Whitfield, P., Major, H., Leweke, F.M., Koethe, D., McKenna, P., Bahn, S., (2008) J. Proteome Res, 7, pp. 4266-4277 Craig, W.Y., Palomaki, G.E., Haddow, J.E., (1989) Br. Med. J, 298, pp. 784-788 Siegel, G.J., Albers, R.W., Brady, S., Price, D.L., (2006) Basic Neurochemistry: Moleclular, Cellular and Medical Aspects, , 2nd ed, Academic Press: London Stoll, A.L., Sachs, G.S., Cohen, B.M., Lafer, B., Christensen, J.D., Renshaw, P.F., (1996) Biol. Psychiatry, 40, pp. 382-388 Yildiz-Yesiloglu, A., Ankerst, D.P., (2006) Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 30, pp. 969-995 Forester, B.P., Finn, C.T., Berlow, Y.A., Wardrop, M., Renshaw, P.F., Moore, C.M., (2008) Bipolar Disord, 10, pp. 691-700